Upperville, VA, United States of America

Lynn S Grinna



Average Co-Inventor Count = 2.0

ph-index = 8

Forward Citations = 256(Granted Patents)


Location History:

  • Santa Monica, CA (US) (1992 - 1996)
  • Upperville, VA (US) (1999 - 2001)
  • Middleburg, CA (US) (2001)
  • Middleburg, VA (US) (1995 - 2004)

Company Filing History:


Years Active: 1992-2004

Loading Chart...
Loading Chart...
15 patents (USPTO):Explore Patents

Title: The Innovative Mind of Lynn S. Grinna

Introduction

Lynn S. Grinna, based in Upperville, Virginia, is a remarkable inventor with a significant impact in the field of biotechnology. With an impressive portfolio of 15 patents, his work primarily focuses on developing novel bactericidal protein products that hold great potential in medical applications.

Latest Patents

One of his latest patents is centered on stable bactericidal/permeability-increasing (BPI) protein products. This innovation involves altering specific amino acid residues to enhance the efficacy of these proteins. Specifically, the patent details modifications where cysteine residue number 132 or 135 is replaced with alanine or serine, and the leucine residue at position 193 serves as the carboxy terminal residue. Furthermore, the patent also outlines DNA sequences encoding methods of producing these proteins in appropriate host cells, as well as stable pharmaceutical compositions suitable for treating gram-negative bacterial infections and their sequelae.

Career Highlights

Lynn S. Grinna's professional journey includes significant roles at Xoma Corporation and International Genetic Engineering, where his contributions to biopharmaceutical developments have been noteworthy. His expertise in engineering bactericidal proteins has paved the way for advancements in treating bacterial infections, illustrating his dedication to enhancing healthcare through innovation.

Collaborations

Throughout his career, Grinna has collaborated with esteemed colleagues, including Georgia Theofan and Arnold H. Horwitz. These partnerships have fostered a synergistic environment conducive to scientific discovery and innovation in the realm of biotechnology.

Conclusion

Lynn S. Grinna exemplifies the spirit of innovation in the biotechnology sector. His contributions through patented inventions not only showcase his inventiveness but also his commitment to improving medical treatments for bacterial infections. As he continues to develop his ideas, his work remains at the forefront of the industry, influencing future advancements in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…